NLRP3 and acute respiratory distress syndrome: Given NLRP3-mediated inflammation and cytokine storm are associated with disease severity in IAV and SARS-CoV-2 infection (179), suppressing NLRP3 inflammasome hyperactivation and cytokine storm may alleviate acute respiratory distress syndrome (ARDS).